Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 8-K: Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Clearside Biomedical | 8-K: Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
Clearside Biomedical | DEFA14A: Others
Clearside Biomedical | DEF 14A: Definitive information statements
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 8-K: Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 8-K: Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | 8-K: Clearside Biomedical Announces Second Quarter 2023 Financial Results and Provides Corporate Update
Clearside Biomedical | 8-K: Current report
Clearside Biomedical | S-3: Registration statement for specified transactions by certain issuers
Clearside Biomedical | 8-K: Current report
No Data
No Data